Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.3300 (0.5%) ($28.0500 - $28.7400) on Wed. Aug. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.34% (three month average) | RSI | 58 | Latest Price | $28.3300(0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(47%) IWC(44%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.17% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) EDOC(-3%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.17% (StdDev 2.34%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $28.41(-0.28%) | 10 Day Moving Average | $28.55(-0.77%) | 20 Day Moving Average | $28.16(0.6%) | To recent high | -4.3% | To recent low | 24.1% | Market Cap | $3.872b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |